Abstract
Background
To compare the NaF uptake in the thoracic aorta and whole heart, as an early indicator of atherosclerosis, in multiple myeloma (MM) and smoldering multiple myeloma (SMM) patients with a healthy control (HC) group.
Methods
Forty-four untreated myeloma patients (35 MM and nine SMM) and twenty-six age and gender-matched HC subjects were collected. Each individual’s NaF uptake in three parts of the aorta (AA: ascending aorta, AR: aortic arch, DA: descending aorta) and the whole heart was segmented. Average global standardized uptake value means were derived by sum of the product of each slice area divided by the sum of those slice areas. Results were reported as target to background ratio (TBR).
Results
There was a significant difference between the NaF uptake in the thoracic aorta of myeloma and HC groups [AA (myeloma = 1.82 ± 0.21, HC = 1.24 ± 0.02), AR (myeloma = 1.71 ± 0.19, HC = 1.28 ± 0.03) and DA (myeloma = 1.96 ± 0.28, HC = 1.38 ± 0.03); P-values < 0.001]. The difference in the whole heart NaF uptake between two groups was also significant (P < 0.001).
Conclusions
We observed a higher uptake of NaF in the thoracic aorta and whole heart of myeloma patients in comparison to the matched control group.
Similar content being viewed by others
Abbreviations
- AA:
-
Ascending aorta
- AR:
-
Aortic arch
- DA:
-
Descending aorta
- BA:
-
Background activity
- CVD:
-
Cardiovascular disease
- NaF:
-
18F-sodium fluoride
- CT:
-
Computed tomography
- MRI:
-
Magnetic resonance imaging
- CVR:
-
Cardiovascular risk factor
- PET:
-
Positron emission tomography
- SUV:
-
Standardized uptake value
- TBR:
-
Target to background ratio
- ROI:
-
Regions of interest
- MM:
-
Multiple myeloma
- SMM:
-
Smoldering multiple myeloma
- TAC:
-
Thoracic aorta calcification
- HC:
-
Healthy control
- MGUS:
-
Monoclonal gammopathy of undetermined significance
- LDCT:
-
Low-dose CT
- mCS:
-
Microscopic calcium score
- rmCS:
-
Relative microscopic calcium score
- CS:
-
Ca score
References
Koene RJ, Prizment AE, Blaes A, Konety SH. Shared risk factors in cardiovascular disease and cancer. Circulation 2016;133:1104-14.
Plummer C, Driessen C, Szabo Z, Mateos M-V. Management of cardiovascular risk in patients with multiple myeloma. Blood Cancer J 2019;9(3):26.
Rajkumar SV. Multiple myeloma: 2018 update on diagnosis, risk-stratification, and management. Am J Hematol 2018;93:1091-110.
Rosa GM, Bauckneht M, Masoero G, Mach F, Quercioli A, Seitun S, et al. The vulnerable coronary plaque: Update on imaging technologies. Thrombos Haemostas 2013;110:706-22.
Giannopoulos AA, Benz DC, Gräni C, Buechel RR. Imaging the event-prone coronary artery plaque. J Nucl Cardiol 2019;26:141-53.
Huang H, Virmani R, Younis H, Burke AP, Kamm RD, Lee RT. The impact of calcification on the biomechanical stability of atherosclerotic plaques. Circulation 2001;103:1051-6.
Dweck MR, Joshi FR, Newby DE, Rudd JH. Noninvasive imaging in cardiovascular therapy: The promise of coronary arterial 18F-sodium fluoride uptake as a marker of plaque biology. Expert Rev Cardiovasc Ther 2012;10:1075-7.
Arani LS, Gharavi MH, Seraj SM, et al. Association between age, uptake of 18F-fluorodeoxyglucose and of 18F-sodium fluoride, as cardiovascular risk factors in the abdominal aorta. Hell J Nucl Med 2019;22:14-9.
Matter CM, Stuber M, Nahrendorf M. Imaging of the unstable plaque: How far have we got? Eur Heart J 2009;30:2566-74.
Raynor W, Houshmand S, Gholami S, Emamzadehfard S, Rajapakse CS, Blomberg BA, et al. Evolving role of molecular imaging with 18F-sodium fluoride PET as a biomarker for calcium metabolism. Curr Osteoporos Rep 2016;14:115-25.
Slomka PJ, Pan T, Berman DS, Germano G. Advances in SPECT and PET hardware. Prog Cardiovasc Dis 2015;57:566-78.
Johnson T, Ding H, Lipinski J, Molloi S. SU‐E‐I‐25: Quantification of coronary artery cross-sectional area in CT angiography using integrated density: A simulation study. Med Phys 2015;42:3247.
Fiz F, Morbelli S, Bauckneht M, Piccardo A, Ferrarazzo G, Nieri A, et al. Correlation between thoracic aorta 18F-natrium fluoride uptake and cardiovascular risk. World J Radiol 2016;8:82.
Tison GH, Guo M, Blaha MJ, McClelland RL, Allison MA, Szklo M, et al. Multisite extracoronary calcification indicates increased risk of coronary heart disease and all-cause mortality: The multi-ethnic study of atherosclerosis. J Cardiovasc Comput Tomogr 2015;9:406-14.
Adar A, Erkan H, Gokdeniz T, Karadeniz A, Cavusoglu IG, Onalan O. Aortic arch calcification is strongly associated with coronary artery calcification. VASA Zeitschrift fur Gefasskrankheiten 2015;44:106-14.
Beheshti M, Mottaghy FM, Paycha F, Behrendt FFF, Van den Wyngaert T, Fogelman I, et al. (18)F-NaF PET/CT: EANM procedure guidelines for bone imaging. Eur J Nucl Med Mol Imaging 2015;42:1767-77.
Boellaard R, Delgado-Bolton R, Oyen WJ, Giammarile F, Tatsch K, Eschner W, et al. FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging 2015;42:328-54.
Blomberg BA, Thomassen A, Takx RA, Vilstrup MH, Hess S, Nielsen AL, et al. Delayed sodium 18F-fluoride PET/CT imaging does not improve quantification of vascular calcification metabolism: Results from the CAMONA study. J Nucl Cardiol 2014;21:293-304.
Cho I-J, Chang H-J, Cho I, Heo R, Lee S-E, Shim CY, et al. Association of thoracic aorta calcium score with exercise blood pressure response and clinical outcomes in elderly individuals: Differential impact of aorta calcification compared with coronary artery calcification. J Am Heart Assoc 2016. https://doi.org/10.1161/JAHA.115.003131.
Lenihan DJ, Potluri R, Bhandari H, Ranjan S, Chen C. Evaluation of cardiovascular comorbidities among patients with multiple myeloma in the United States. 2016.
Blomberg BA, de Jong PA, Thomassen A, Lam MGE, Vach W, Olsen MH, et al. Thoracic aorta calcification but not inflammation is associated with increased cardiovascular disease risk: Results of the CAMONA study. Eur J Nucl Med Mol Imaging 2017;44:249-58.
Kitagawa T, Yamamoto H, Toshimitsu S, Sasaki K, Senoo A, Kubo Y, et al. (18)F-sodium fluoride positron emission tomography for molecular imaging of coronary atherosclerosis based on computed tomography analysis. Atherosclerosis 2017;263:385-92.
Evans NR, Tarkin JM, Chowdhury MM, Warburton EA, Rudd JHF. PET Imaging of atherosclerotic disease: Advancing plaque assessment from anatomy to pathophysiology. Curr Atheroscler Rep 2016;18:30.
de Oliveira-Santos M, Castelo-Branco M, Silva R, Gomes A, Chichorro N, Abrunhosa A, et al. Atherosclerotic plaque metabolism in high cardiovascular risk subjects–A subclinical atherosclerosis imaging study with 18F-NaF PET-CT. Atherosclerosis 2017;260:41-6.
Seraj SM, Raynor WY, Mona-Elisabeth R, et al. Assessing the feasibility of NaF-PET/CT versus FDG-PET/CT to detect abdominal aortic calcification or inflammation in rheumatoid arthritis patients. Ann Nucl Med 2020. https://doi.org/10.1007/s12149-020-01463-w.
Czernin J, Satyamurthy N, Schiepers C. Molecular mechanisms of bone 18F-NaF deposition. J Nucl Med 2010;51:1826-9.
Derlin T, Richter U, Bannas P, Begemann P, Buchert R, Mester J, et al. Feasibility of 18F-sodium fluoride PET/CT for imaging of atherosclerotic plaque. J Nucl Med 2010;51:862-5.
Derlin T, Wisotzki C, Richter U, Apostolova I, Bannas P, Weber C, et al. In vivo imaging of mineral deposition in carotid plaque using 18F-sodium fluoride PET/CT: Correlation with atherogenic risk factors. J Nucl Med 2011;52:362-8.
Beheshti M, Saboury B, Mehta NN, Torigian DA, Werner T, Mohler E, et al. Detection and global quantification of cardiovascular molecular calcification by fluoro18-fluoride positron emission tomography/computed tomography–a novel concept. Hell J Nucl Med 2011;14:114-20.
McKenney-Drake ML, Moghbel MC, Paydary K, Alloosh M, Houshmand S, Moe S, et al. (18)F-NaF and (18)F-FDG as molecular probes in the evaluation of atherosclerosis. Eur J Nucl Med Mol Imaging 2018;45:2190-200.
Mohler ER, Alavi A, Wilensky RL. 18F-fluoride imaging for atherosclerosis. J Am Coll Cardiol 2012;60:1711-2.
Driver JA, Djousse L, Logroscino G, Gaziano JM, Kurth T. Incidence of cardiovascular disease and cancer in advanced age: Prospective cohort study. BMJ (Clinical research ed) 2008;337:a2467.
Fairweather DL. Sex differences in inflammation during atherosclerosis. Clin Med Insights Cardiol 2014;8:49-59.
Jaiswal S, Natarajan P, Silver AJ, et al. Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease. N Engl J Med 2017;377:111-21.
Mouhieddine TH, Park J, Redd RA, et al. The role of clonal hematopoiesis of indeterminate potential (CHIP) in multiple myeloma: Immunomodulator maintenance post autologous stem cell transplant (ASCT) predicts better outcome. Blood 2018;132:749.
Gu X, He Y, Li Z, et al. Relation between the incidence, location, and extent of thoracic aortic atherosclerosis detected by transesophageal echocardiography and the extent of coronary artery disease by angiography. Am J Cardiol 2011;107:175-8.
Wasilewski J, Kiljański T. Biomechaniczna przyczyna miażdżycy. Wydaw. Politechniki Łódzkiej. rozdział 11 (in Polish). 2011.
Disclosure
All authors declare that they have no conflict of interest.
Ethical Approval
The protocol was approved by the Danish Ethics Committee (S-20120209), the Danish Data Protection Agency (2008-58-0035) and registered at clinicaltrials.gov (NCT02187731 and NCT01724749).
Informed Consent
Informed consent was obtained from all individual participants included in the study.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Funding
The project was funded by the Region of Southern Denmark, University of Southern Denmark, Odense University Hospital, Harboe Foundation, The A.P.Møller Foundation (Fonden til lægevidenskabens fremme), Aase & Ejnar Danielsen Foundation, The Family Hede Nielsen Foundation.
The authors of this article have provided a PowerPoint file, available for download at SpringerLink, which summarises the contents of the paper and is free for re-use at meetings and presentations. Search for the article DOI on SpringerLink.com.
The authors have also provided an audio summary of the article, which is available to download as ESM, or to listen to via the JNC/ASNC Podcast.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Arani, L.S., Zirakchian Zadeh, M., Saboury, B. et al. Assessment of atherosclerosis in multiple myeloma and smoldering myeloma patients using 18F- sodium fluoride PET/CT. J. Nucl. Cardiol. 28, 3044–3054 (2021). https://doi.org/10.1007/s12350-020-02446-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12350-020-02446-0